Like many Americans, Laura Bray had no idea the generic-drug market was broken until four years ago, when her then-9-year-old girl, Abby, missed treatment for leukemia because the hospital's supply of a $10 drug ran out.
"We were told that the most important thing that we could do as parents to help her survive was compliance with the drug regimen — every single day, every single time," Bray says. Yet there was no drug to give.
